FYB202 Project GmbH is a company based in Planegg-Martinsried. It is registered in the commercial register of the München local court under HRB 276520. The company was founded in 2017. In 2025, the company reported revenue of €11,360,000.
Entwicklung des Biosimilars Ustekinumab, sowie die damit verbundene und die hierauf gerichtete Forschung, um letztlich die Zulassung für eine humanmedizinische Behandlung zu erhalten, die dann kommerzialisiert werden kann und soll.
Source: German Commercial Register (Handelsregister) München Local Court, HRB 276520 (as of 4 September 2026)
Source: German Commercial Register (Handelsregister) München Local Court, HRB 276520 (as of 4 September 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 276520 (as of 4 September 2026)
Sign in to view detailed salary and cost trends.
